Rxcurve
HCPCS J9393 · per 25 MG

Inj, fulvestrant (teva)

This code is not in the latest file (4Q26). It was last listed in 3Q23.

Payment limit per 25 MG, by effective quarter, 1Q23 to 3Q23. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9393

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
3Q23 $21.20 +$18.131 25 MG Inj, fulvestrant (teva) v1, posted June 5, 2024
2Q23 $3.069 −$12.374 25 MG Inj, fulvestrant (teva) v1, posted February 23, 2024
1Q23 $15.443 – 25 MG Inj, fulvestrant (teva) v1, posted December 6, 2023

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files